光啟技術(002625.SZ):子公司進入某重要客户合格供方名錄
格隆匯12月18日丨光啟技術(002625.SZ)公佈,2020年7月18日,公司披露了下屬子公司深圳光啟尖端技術有限責任公司(簡稱“光啟尖端”)通過了成都某重要客户的外包合格供方資格審查,具備復材結構件合格供方生產資質。
公司近日收到光啟尖端的通知,光啟尖端於2020年12月17日進入了成都某另一重要客户B的合格供方名錄,可以為該客户提供研製服務,研製完成後可進行產品的批產交付。
該次進入該重要客户的合格供方名錄,標誌着越來越多的尖端裝備領域的客户高度認可了公司提供的產品與服務,是公司超材料業務在尖端裝備領域具備較強競爭力的有力證明,預計會對公司後續年度的經營業績產生積極影響,為公司繼續開拓尖端裝備市場奠定良好基礎。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.